agm-renewal of proportional takeover provision

AGMs tmr. i guess we should be having the Renewal of Proportional Takeover Provisions.


food for tot, have a look at how big pharma does M&A. Roche saying its interested in v targeted acquisitions and the most recent being Anadys (230% premium).

the renewal of the above provision will protect SH's interest in the long term although i have to say that 230% is tempting (short term).


22oct2011
http://www.businessweek.com/news/2011-10-21/roche-seeks-targeted-acquisitions-not-abbott-sized-deal.html

“We’ve focused on smaller, bolt-on acquisitions,” Schwan said in an interview today in Frankfurt when asked whether an acquisition of a portion of Abbott’s business is attractive. “That’s how I see us continuing in our M&A strategy. We are not interested in mega-mergers. We are interested in very targeted acquisitions which complement our technologies and portfolios.”


18oct2011
http://www.skynews.com.au/finance/article.aspx?id=674700&vId=

Swiss drugmaker Roche Holding has announced it is paying $US230 million ($A223.4 million) to take over Anadys Pharmaceuticals, a US-based specialist in the development of hepatitis C treatments. The offer amounts to $US3.70 per share, a premium of more than 250 per cent on Anadys's closing price on Friday, Roche said.